NANO2 Trademark

Trademark Overview

On Friday, July 5, 2019, a trademark application was filed for NANO2 with the United States Patent and Trademark Office. The USPTO has given the NANO2 trademark a serial number of 88501697. The federal status of this trademark filing is REGISTERED as of Tuesday, April 20, 2021. This trademark is owned by NuvOx, Pharma, LLC. The NANO2 trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of diseases associated with hypoxia
nano2

General Information

Serial Number88501697
Word MarkNANO2
Filing DateFriday, July 5, 2019
Status700 - REGISTERED
Status DateTuesday, April 20, 2021
Registration Number6329507
Registration DateTuesday, April 20, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of diseases associated with hypoxia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2019
Primary Code005
First Use Anywhere DateTuesday, July 9, 2019
First Use In Commerce DateSaturday, January 30, 2021

Trademark Owner History

Party NameNuvOx, Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressTucson, AZ 85719
Party NameNuvOx, Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressTucson, AZ 85719
Party NameNuvOx, Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTucson, AZ 85719

Trademark Events

Event DateEvent Description
Tuesday, April 20, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 16, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, March 14, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 16, 2020NON-FINAL ACTION E-MAILED
Sunday, August 16, 2020SU - NON-FINAL ACTION - WRITTEN
Saturday, August 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 5, 2020ASSIGNED TO LIE
Wednesday, July 29, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 14, 2020USE AMENDMENT FILED
Wednesday, July 29, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 14, 2020TEAS STATEMENT OF USE RECEIVED
Monday, June 15, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, January 21, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 17, 2019ASSIGNED TO LIE
Thursday, October 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 4, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 4, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 30, 2019NON-FINAL ACTION E-MAILED
Monday, September 30, 2019NON-FINAL ACTION WRITTEN
Monday, September 23, 2019ASSIGNED TO EXAMINER
Monday, July 15, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 9, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

nano associated hypoxia diseases prevention preparations pharmaceutical